COVID-19 vaccine weekly safety report - 05-08-2021
Release date
Vaccination against COVID-19 is one of the most effective ways to reduce severe illness and death from infection. Two COVID-19 vaccines are currently in use in Australia – AstraZeneca and Comirnaty (Pfizer). Like all medicines, the vaccines can have side effects (also known as adverse events). The overwhelming majority of these are mild and resolve within a few days. The Therapeutic Goods Administration (TGA) closely monitors suspected side effects. Importantly, adverse events reported to the TGA are often not caused by the vaccine itself. Learn more about causality.
Learn about the TGA’s COVID-19 vaccine safety monitoring and reporting activities or report a suspected side effect.Summary
-
To 1 August 2021, approximately 12.4 million vaccine doses have been given in Australia – 8.4 million first doses and 4 million second doses.
-
The TGA is continually monitoring the safety of the COVID-10 vaccines. The most frequently reported side effects suspected to be associated with the vaccines reflect what was seen in the clinical trials and include injection-site reactions such as a sore arm, and more general symptoms such as headache, muscle pain, fever and chills.
-
We are closely monitoring rare reports of blood clots with low blood platelets (also called thrombosis with thrombocytopenia or TTS) following the AstraZeneca vaccine.
-
Three additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia syndrome (TTS) likely to be linked to the AstraZeneca vaccine. When assessed using the United Kingdom (UK) case definition, 2 were confirmed and one was deemed probable TTS. Sadly, a 34-year-old woman from NSW died yesterday from confirmed TTS following a first dose of the AstraZeneca vaccine. The TGA extends its sincerest condolences to her family and loved ones. We are in close communication with NSW health who are undertaking further investigation of this case.
-
The TGA is also closely monitoring reports of suspected immune thrombocytopenia (ITP) and Guillain-Barre Syndrome (GBS) following the AstraZeneca vaccine and reports of myocarditis and pericarditis following the Comirnaty (Pfizer) vaccine.
-
The protective benefits of vaccination against COVID-19 far outweigh the potential risks of vaccination.
https://www1.racgp.org.au/newsgp/clinical/no-deaths-in-latest-tga-vaccine-safety-report
So, what is to be? Is the TGA report "medical misadventure"?Seems pretty unambiguous to me.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.